{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:21:20Z","timestamp":1788128480406,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vaccination is a key strategy to reduce infectious disease mortality. In pediatric heart transplant recipients (HTRs), the use of immunosuppressive therapy weakens immune responses, increasing the risk of viral infections. This study aimed to evaluate the immunogenicity of hepatitis B virus (HBV) revaccination in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective longitudinal study was conducted in HTRs under 18 years of age who received HBV revaccination. Blood samples were collected at study inclusion (baseline) and after the final vaccine dose post-solid organ transplant (SOT; follow-up). Seroprotection was measured by quantifying plasma antibodies to hepatitis B surface antigen (anti-HBs) IgG. Cellular responses were assessed by flow cytometry, evaluating HBV-specific T-cell and natural killer (NK) cell activity following in vitro stimulation with HBV peptides.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-three patients (median age, 9 years; 70% male) were included, with a median posttransplant time of 13 months. All received tacrolimus; most received mycophenolate (87%) and corticosteroids (39%). Post-SOT seroprotection was achieved in 48% of patients, and 82% showed HBV-specific CD4+ and CD8+ T-cell responses. Higher vaccine doses (3\u20134 doses) were associated with stronger immune responses. NK cell responses were observed in 56% (total NK cells) and 61% (NK T cells). NK responders showed higher expression of the activating receptor NKG2C. Baseline monocyte, dendritic cell and memory T-cell frequencies were positively correlated with post-SOT vaccination response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pediatric HTRs showed a generally good immune response to HBV revaccination, especially with higher vaccine doses. The immune profile at the time of vaccination appears to influence outcomes, supporting personalized vaccination approaches in immunosuppressed populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004958","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:02:33Z","timestamp":1757509353000},"page":"80-88","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Prospective Cohort Study of Hepatitis B Virus Vaccination in Pediatric Heart Transplant Recipients: Cellular and Humoral Immune Responses and the Role of Innate Immunity"],"prefix":"10.1097","volume":"45","author":[{"given":"Beatriz","family":"Lazaro-Martin","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Biomedical Research Centre Network for Infectious Diseases, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tarancon-Diez","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Biomedical Research Centre Network for Infectious Diseases, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Camino Lopez","sequence":"additional","affiliation":[{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Pediatric Cardiology Department, Gregorio Mara\u00f1\u00f3n Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Alonso","sequence":"additional","affiliation":[{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Clinical Microbiology and Infectious Diseases Department, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"},{"name":"Complutense University, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Gil Villanueva","sequence":"additional","affiliation":[{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Pediatric Cardiology Department, Gregorio Mara\u00f1\u00f3n Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Molecular Immunology Laboratory, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Biomedical Research Centre Network for Bioengineering, Biomaterials and Nanomedicine, Carlos III Health Institute, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Hernanz-Lobo","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Biomedical Research Centre Network for Infectious Diseases, Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Navarro Gomez","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"},{"name":"Gregorio Mara\u00f1\u00f3n Research Health Institute, Madrid, Spain"},{"name":"Biomedical Research Centre Network for Infectious Diseases, Carlos III Health Institute, Madrid, Spain"},{"name":"Complutense University, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/petr.12205","article-title":"Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients.","volume":"18","author":"Mouledoux","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"e13400","DOI":"10.1111\/ctr.13400","article-title":"Allergies and autoimmune disorders in children after heart transplantation.","volume":"32","author":"Avdimiretz","year":"2018","journal-title":"Clin Transplant"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2017.05.009","article-title":"Bacterial infections after pediatric heart transplantation: epidemiology, risk factors and outcomes.","volume":"36","author":"Rostad","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.22882","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.","volume":"49","author":"Weinbaum","year":"2009","journal-title":"Hepatology"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12879-024-09201-7","article-title":"Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014\u20132017.","volume":"24","author":"Sperle","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12879-015-1000-2","article-title":"HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.","volume":"15","author":"Bekondi","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"e13247","DOI":"10.1111\/ctr.13247","article-title":"Durability of the hepatitis B vaccination in pediatric renal transplant recipients.","volume":"32","author":"Miller\u2010Handley","year":"2018","journal-title":"Clin Transplant"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ajt.12987","article-title":"High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients.","volume":"15","author":"Leung","year":"2015","journal-title":"Am J Transplant"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-3046.2006.00527.x","article-title":"Immunization issues before and after solid organ transplantation in children.","volume":"10","author":"Verma","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1056\/NEJMcp041507","article-title":"Prevention of hepatitis B with the HEPATITIS B vaccine.","volume":"351","author":"Poland","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omtm.2021.03.012","article-title":"Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity.","volume":"21","author":"Awad","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R13-20251215","first-page":"357","article-title":"HBV vaccination and HBV infection induces HBV-specific natural killer cell memory.","volume":"70","author":"Wijaya","year":"2021","journal-title":"Gut"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.vaccine.2012.11.029","article-title":"Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level.","volume":"31","author":"Carollo","year":"2013","journal-title":"Vaccine"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vacun.2024.07.002","article-title":"Importance of optimizing routine immunization schedules in pediatric heart transplantation.","volume":"25","author":"Bassy Navarro","year":"2024","journal-title":"Vacunas"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"e41584","DOI":"10.1016\/j.heliyon.2024.e41584","article-title":"Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients.","volume":"11","author":"Bermejo-G\u00f3mez","year":"2025","journal-title":"Heliyon"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anpedi.2023.11.004","article-title":"Consensus document of the Spanish Society of Paediatric Infectious Diseases and the Advisory Committee on Vaccines of the Spanish Association of Pediatrics for Vaccination of Immunosuppressed Individuals.","volume":"99","author":"Rivero Calle","year":"2023","journal-title":"Anales de pediatria"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14218\/JCTH.2018.00037","article-title":"Hepatitis B vaccine and immunoglobulin: key concepts.","volume":"7","author":"Das","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/JVI.07034-11","article-title":"Differential gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.","volume":"86","author":"Ferrando-Mart\u00ednez","year":"2012","journal-title":"J Virol"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1399-3046.2012.01760.x","article-title":"Response to hepatitis A and B vaccination after pediatric heart transplant.","volume":"16","author":"Martin","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"e13920","DOI":"10.1111\/petr.13920","article-title":"Vaccine\u2010induced protection against hepatitis B in pediatric solid organ transplant patients.","volume":"25","author":"Ball","year":"2021","journal-title":"Pediatr Transplant"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jmv.1094","article-title":"Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.","volume":"65","author":"Van Damme","year":"2001","journal-title":"J Med Virol"},{"key":"R24-20251215","article-title":"Vaccination for people who are immunocompromised.","year":"2023","journal-title":"Australian Immunisation Handbook"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajt.2023.12.011","article-title":"Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients: a nationwide retrospective study.","volume":"24","author":"Gold","year":"2024","journal-title":"Am J Transplant"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/vaccines11071166","article-title":"Humoral and cellular immunity following five doses of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.","volume":"11","author":"Alotaibi","year":"2023","journal-title":"Vaccines"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series.","volume":"174","author":"Werbel","year":"2021","journal-title":"Ann Intern Med"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1097\/TP.0000000000003934","article-title":"Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series.","volume":"105","author":"Alejo","year":"2021","journal-title":"Transplantation"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"e22223","DOI":"10.5812\/hepatmon.22223","article-title":"Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination.","volume":"14","author":"Saffar","year":"2014","journal-title":"Hepat Mon"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.vaccine.2008.08.054","article-title":"Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.","volume":"26","author":"Nystr\u00f6m","year":"2008","journal-title":"Vaccine"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"103464","DOI":"10.1016\/j.ebiom.2021.103464","article-title":"Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss.","volume":"69","author":"Xiong","year":"2021","journal-title":"eBioMedicine"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back.","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/eci.12132","article-title":"Training innate immunity: the changing concept of immunological memory in innate host defence.","volume":"43","author":"Netea","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"e1011159","DOI":"10.1371\/journal.ppat.1011159","article-title":"Streptococcus pneumoniae drives specific and lasting Natural Killer cell memory.","volume":"19","author":"Camarasa","year":"2023","journal-title":"PLoS Pathog"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-20251215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12977-018-0450-1","article-title":"Friend retrovirus infection induces the development of memory-like natural killer cells.","volume":"15","author":"Littwitz-Salomon","year":"2018","journal-title":"Retrovirology"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2018.10.006","article-title":"NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection.","volume":"70","author":"Schuch","year":"2019","journal-title":"J Hepatol"},{"key":"R38-20251215","doi-asserted-by":"crossref","first-page":"e182660","DOI":"10.1172\/jci.insight.182660","article-title":"NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.","volume":"9","author":"S\u00e1nchez-Gaona","year":"2024","journal-title":"JCI Insight"},{"key":"R39-20251215","doi-asserted-by":"crossref","first-page":"e20073","DOI":"10.1097\/MD.0000000000020073","article-title":"NKG2C+ natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV.","volume":"99","author":"Song","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R40-20251215","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"R41-20251215","first-page":"229","article-title":"Hepatitis B vaccine and NK cells: a new player in memory.","author":"Hofmann","year":"2020","journal-title":"Gut"},{"key":"R42-20251215","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1111\/j.1600-6143.2009.02917.x","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients.","volume":"9","author":"Danzinger-Isakov","year":"2009","journal-title":"Am J Transplant"},{"key":"R43-20251215","doi-asserted-by":"crossref","first-page":"e002650","DOI":"10.1136\/rmdopen-2022-002650","article-title":"Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.","volume":"8","author":"Frommert","year":"2022","journal-title":"RMD Open"},{"key":"R44-20251215","doi-asserted-by":"crossref","first-page":"e14272","DOI":"10.1111\/petr.14272","article-title":"Responsiveness to second and third dose of mRNA COVID\u201019 vaccination in adolescent and young adult heart transplant recipients.","volume":"26","author":"Feingold","year":"2022","journal-title":"Pediatr Transplant"},{"key":"R45-20251215","doi-asserted-by":"crossref","first-page":"1091237","DOI":"10.3389\/fimmu.2023.1091237","article-title":"Single-cell RNA sequencing reveals the transcriptomic characteristics of peripheral blood mononuclear cells in hepatitis B vaccine non-responders.","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"R46-20251215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.anai.2018.03.017","article-title":"Hepatitis B vaccine nonresponders: possible mechanisms and solutions.","volume":"121","author":"Saco","year":"2018","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:01:07Z","timestamp":1765803667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004958","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}